Items where Author is "Ortmann, O."
 | Up a level |
Article
Ortmann, O. and Blohmer, J-U and Sibert, N. T. and Brucker, S. and Janni, W. and Wockel, A. and Scharl, A. and Dieng, S. and Ferencz, J. and Inwald, E. C. and Wesselmann, S. and Kowalski, C. (2023) Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 149 (3). pp. 1195-1209. ISSN 0171-5216, 1432-1335
Fernandez-Pacheco, M. and Ortmann, O. and Ignatov, A. and Inwald, E. C. (2023) Does cavity margin shaving reduce residual tumor and re-excision rates? A systematic review. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 307 (4). pp. 1295-1309. ISSN 0932-0067, 1432-0711
Hatzipanagiotou, M. E. and Pigerl, M. and Gerken, M. and Raepple, S. and Zeltner, V. and Hetterich, M. and Ugocsai, P. and Inwald, E. C. and Klinkhammer-Schalke, M. and Ortmann, O. and Seitz, S. (2023) Effects of delaying adjuvant chemotherapy initiation on clinical outcomes in early triple-negative breast cancer patients. ANNALS OF ONCOLOGY, 34. S285-S285. ISSN 0923-7534, 1569-8041
Huber, D. and Seitz, S. and Kast, K. and Emons, G. and Ortmann, O. (2022) Correction to: Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review (vol 301, pg 875, 2020). ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 305. p. 1627. ISSN 0932-0067, 1432-0711
Galas, K. and Gleitsmann, M. and Rey, J. and Solbach, C. and Witzel, I. and Seliger, B. and Karn, T. and Schmatloch, S. and Schneeweiss, A. and Sinn, B. V. and Fehm, T. N. and Denkert, C. and Litmeyer, A-S. and Jank, P. and Furlanetto, J. and Ortmann, O. and Van Mackelenbergh, M. T. and Nekljudova, V. and Loibl, S. (2022) Tumor biology and immunology in patients (pts) with breast cancer occurring during pregnancy (BCP) compared to non-pregnant breast cancer pts. ANNALS OF ONCOLOGY, 33 (Suppl7). S608-S609. ISSN 0923-7534, 1569-8041
Ortmann, O. and Torode, J. and Schmiegel, W. and Thomssen, C. and Hakama, M. and Basu, P. and Ringborg, U. and Helbig, U. (2020) Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 146 (7). pp. 1813-1818. ISSN 0171-5216, 1432-1335
Huber, D. and Seitz, S. and Kast, K. and Emons, G. and Ortmann, O. (2020) Use of fertility treatments inBRCA1/2mutation carriers and risk for ovarian and breast cancer: a systematic review. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 302 (3). pp. 715-720. ISSN 0932-0067, 1432-0711
Huber, D. and Seitz, S. and Kast, K. and Emons, G. and Ortmann, O. (2020) Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 301 (4). pp. 875-884. ISSN 0932-0067, 1432-0711
Inwald, E. C. and Kowalski, C. and Wesselmann, S. and Ferencz, J. and Ortmann, O. (2019) Recommendation of adjuvant trastuzumab treatment in HER-2-positive breast cancer patients: insights from quality indicator data collected in certified breast cancer centers in Germany, Italy, Austria, and Switzerland. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 300 (2). pp. 383-388. ISSN 0932-0067, 1432-0711
Wege, A. K. and Weber, F. and Ortmann, O. and Nimmerjahn, F. and Brockhoff, G. (2018) IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM). ONCOLOGY RESEARCH AND TREATMENT, 41 (suppl1). p. 176. ISSN 2296-5270, 2296-5262
Inwald, E. C. and Ortmann, O. and Koller, M. and Zeman, F. and Hofstaedter, F. and Evert, M. and Brockhoff, G. and Klinkhammer-Schalke, M. (2017) Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. BREAST CANCER RESEARCH AND TREATMENT, 163 (1). pp. 119-130. ISSN 0167-6806, 1573-7217
Korsun, P. and Bals-Pratsch, M. and Ortmann, O. and Markus, S. and Germer, U. (2016) Antenatal Diagnosis of Dizygotic, Monochorionic Twins Following IVFI/CSI Pranatale Diagnose von dizygoten, monochorialen Gemini. GEBURTSHILFE UND FRAUENHEILKUNDE, 76 (6). pp. 727-730. ISSN 0016-5751, 1438-8804
Nemec, W. and Inwald, E. C. and Buchholz, S. and Schalke, M. Klinkhammer and Gerken, M. and Ortmann, O. (2016) Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 294 (4). pp. 825-831. ISSN 0932-0067, 1432-0711
Ortmann, O. and Torode, J. and Helbig, U. (2016) Improving structural development in oncology: transformation of theoretical health care standards and knowledge into a practical approach-2nd European Roundtable Meeting (ERTM), May 8, 2015, Berlin, Germany. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 142 (4). pp. 807-811. ISSN 0171-5216, 1432-1335
Brockhoff, G. and Wege, A. K. and Ortmann, O. and Huber, S. and Buschauer, A. (2016) Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity. ONCOLOGY RESEARCH AND TREATMENT, 39 (Suppl1). pp. 45-46. ISSN 2296-5270, 2296-5262
Inwald, Elisabeth Christine and Koller, M. and Klinkhammer-Schalke, M. and Zeman, F. and Hofstaedter, F. and Gerstenhauer, M. and Brockhoff, G. and Ortmann, O. (2015) 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival. BREAST CANCER RESEARCH AND TREATMENT, 153 (3). pp. 647-658. ISSN 0167-6806, 1573-7217
Inwald, E. C. and Koller, M. and Klinkhammer-Schalke, M. and Zeman, F. and Hofstaedter, F. and Lindberg, P. and Gerstenhauer, M. and Schueler, S. and Treeck, O. and Ortmann, O. (2015) Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 141 (12). pp. 2229-2240. ISSN 0171-5216, 1432-1335
Donders, G. and Bellen, G. and Neven, P. and Grob, P. and Prasauskas, V. and Buchholz, S. and Ortmann, O. (2015) Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (GynoflorA (R)) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 34 (10). pp. 2023-2028. ISSN 0934-9723, 1435-4373
Kwok, C. W. and Treeck, O. and Buchholz, S. and Seitz, S. and Ortmann, O. and Engel, J. B. (2015) Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC). TARGETED ONCOLOGY, 10 (3). pp. 365-373. ISSN 1776-2596, 1776-260X
Buchholz, S. and Moegele, M. and Lintermans, A. and Bellen, G. and Prasauskas, V. and Ortmann, O. and Grob, P. and Neven, P. and Donders, G. (2015) Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer. CLIMACTERIC, 18 (2). pp. 252-259. ISSN 1369-7137, 1473-0804
Inwald, E. C. and Ortmann, O. and Zeman, F. and Koller, M. and Hofstaedter, F. and Gerstenhauer, M. and Klinkhammer-Schalke, M. (2014) Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry. BIOMED RESEARCH INTERNATIONAL: 137304. ISSN 2314-6133, 2314-6141
Schott, S. and Lermann, J. and Rauchfuss, M. and Ortmann, O. and Ditz, S. (2014) Psychosomatic Primary Care in Gynecology-Assessment and Acceptance by Residents for Obstetrics and Gynecology in Germany. GEBURTSHILFE UND FRAUENHEILKUNDE, 74 (6). pp. 569-573. ISSN 0016-5751, 1438-8804
Inwald, E. C. and Klinkhammer-Schalke, M. and Koller, M. and Ortmann, O. (2014) Quality Assurance for Patients with Breast Cancer - the Impact of Clinical Cancer Registries. GEBURTSHILFE UND FRAUENHEILKUNDE, 74 (9). pp. 868-874. ISSN 0016-5751, 1438-8804
Simoes, E. and Brucker, S. and Beckmann, M. W. and Ortmann, O. and Albring, C. and Wallwiener, D. (2013) Cervical Cancer Screening: Defining the Need for Research. GEBURTSHILFE UND FRAUENHEILKUNDE, 73 (3). pp. 239-246. ISSN 0016-5751, 1438-8804
Seitz, S. and Rick, F. G. and Schally, A. V. and Treszl, A. and Hohla, F. and Szalontay, L. and Zarandi, M. and Ortmann, O. and Engel, J. B. and Buchholz, S. (2013) Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. ONCOLOGY REPORTS, 30 (1). pp. 413-418. ISSN 1021-335X
Eggemann, H. and Ignatov, T. and Beni, A. and Costa, S. D. and Ortmann, O. and Ignatov, A. (2013) Intraoperative Ultrasound in the Treatment of Breast Cancer. GEBURTSHILFE UND FRAUENHEILKUNDE, 73 (10). pp. 1028-1034. ISSN 0016-5751, 1438-8804
Inwald, E. C. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Zeman, F. and Koller, M. and Gerstenhauer, M. and Ortmann, O. (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. BREAST CANCER RESEARCH AND TREATMENT, 139 (2). pp. 539-552. ISSN 0167-6806, 1573-7217
Schueler, S. and Ponnath, M. and Lattrich, C. and Ortmann, O. (2013) Reproductive Factors and Risk of Ovarian Cancer. GEBURTSHILFE UND FRAUENHEILKUNDE, 73 (6). pp. 640-648. ISSN 0016-5751, 1438-8804
Simoes, E. and Brucker, S. and Beckmann, M. W. and Ortmann, O. and Albring, C. and Wallwiener, D. (2013) Screening for Cervical Cancer - Minimise Risks - Maximise Benefits. Need for Adaptation in Germany in Light of the European Guidelines and Their Objectives. GEBURTSHILFE UND FRAUENHEILKUNDE, 73 (6). pp. 623-639. ISSN 0016-5751, 1438-8804
Jenewein, N. and Christ, J. and Guenther, D. and Hutsteiner, P. and Ortmann, O. and Germer, U. (2013) Skin Edema in First Trimester Fetuses. ULTRASCHALL IN DER MEDIZIN, 34 (5). pp. 441-445. ISSN 0172-4614, 1438-8782
Harter, P. and Mahner, S. and Hilpert, F. and Runnebaum, I. and Ortmann, O. and Mustea, A. and Sehouli, J. and du Bois, A. and Wagner, U. (2013) Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer. GEBURTSHILFE UND FRAUENHEILKUNDE, 73 (3). pp. 221-223. ISSN 0016-5751, 1438-8804
Moegele, M. and Buchholz, S. and Seitz, S. and Lattrich, C. and Ortmann, O. (2013) Vaginal Estrogen Therapy for Patients with Breast Cancer. GEBURTSHILFE UND FRAUENHEILKUNDE, 73 (10). pp. 1017-1022. ISSN 0016-5751, 1438-8804
Christ, J. and Goecke, T. and Jenewein, N. and Guenther, D. and Ortmann, O. and Germer, U. (2012) Congenital Tracheal occlusion - a Disease with poor prognosis. Considerations for therapy based on two case reports. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P37. ISSN 0016-5751
Seitz, S. and Schally, A. V. and Engel, J. and Weber, F. and Machleidt, A. and Moegele, M. and Ortmann, O. and Buchholz, S. (2012) Effective Therapy of triple-negative Breast Carcinoma with the GHRH-Antagonist JMR-132 in Combination with Docetaxel. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P10. ISSN 0016-5751
Machleidt, A. and Diermeier-Daucher, S. and Moegele, M. and Seitz, S. and Klinikhammer-Schalke, M. and Buchholz, S. and Ortmann, O. and Brockhoff, G. (2012) Her4-JMa-Receptor as positive prognostic Marker in triple-negative Breast Cancer. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P57. ISSN 0016-5751
Guenther, D. and Hottner, S. and Christ, J. and Jenewein, N. and Ortmann, O. and Germer, U. (2012) Indications for further allocation to diagnostic ultrasound in the second Trimester at a tertiary Center for prenatal medicine. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P38. ISSN 0016-5751
Jenewein, N. and Christ, J. and Guenther, D. and Hutsteiner, P. and Ortmann, O. and Germer, U. (2012) Outcome of Fetuses with Skin edema in the first Trimester. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P40. ISSN 0016-5751
Inwald, E. C. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Gerken, M. and Gerstenhauer, M. and Ortmann, O. (2012) Representation of the Outcome-Quality of Routine Care of Women with primary Breast Cancer - Data from the clinical Cancer Register of the Tumor Centre Regensburg. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P5. ISSN 0016-5751
Lattrich, C. and Meier, R. and Haering, J. and Schueler, S. and Treeck, O. and Ortmann, O. (2012) Role of estrogen receptor beta in invasion of human breast cancer cells. GEBURTSHILFE UND FRAUENHEILKUNDE, 72 (7). P54. ISSN 0016-5751
Engel, J. B. and Schally, A. V. and Buchholz, S. and Seitz, S. and Emons, G. and Ortmann, O. (2012) Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH). ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 286 (2). pp. 437-442. ISSN 0932-0067
Neven, P. and Donders, G. and Moegele, M. and Lintermans, A. and BeIlen, G. and Ortmann, O. and Buchholz, S. (2012) Ultra-low dose vaginal estriol and Lactobacillus acidophilus (Gynoflo (R)) in early breast cancer survivors on aromatase inhibitors: Pharmacokinetic, efficacy and safety results from a phase I study. CANCER RESEARCH, 72 (24Supp): P2-12-06. ISSN 0008-5472, 1538-7445
Bals-Pratsch, M. and Grosser, B. and Seifert, B. and Ortmann, O. and Seifarth, C. (2011) Early Onset and High Prevalence of Gestational Diabetes in PCOS and Insulin Resistant Women Before and After Assisted Reproduction. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 119 (6). pp. 338-342. ISSN 0947-7349
Brockhoff, G. and Machleidt, A. and Piendl, G. and Seegers, S. and Sassen, A. and Diermeier-Daucher, S. and Buchholz, S. and Ortmann, O. (2011) HER4 Coexpression Is Associated with Improved Recurrence EFree Survival in HER2-Positive, Herceptin Treated Patients. CANCER RESEARCH, 71 (24Supp): P1-12-23. ISSN 0008-5472, 1538-7445
Ortmann, O. and Pagani, O. and Jones, A. and Maass, N. and Noss, D. and Rugo, H. and van de Velde, C. and Aapro, Matti and Coleman, R. (2011) Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel. CANCER TREATMENT REVIEWS, 37 (2). pp. 97-104. ISSN 0305-7372
Noss, D. and Buchholz, S. and Ortmann, O. (2010) Adjuvant Endocrine Therapy for Breast Cancer During Perimenopause. GEBURTSHILFE UND FRAUENHEILKUNDE, 70 (2). pp. 112-116. ISSN 0016-5751
Seitz, S. and Koester, F. and Schally, V. A. and Awatar, K. and Papadia, A. and Ortmann, O. and Buchholz, S. (2010) Amplification effect from inhibitory tamoxifen to the positive estrogen receptor brustkrebs cell lines in-vitro or in vivo by the combination with the new growth hormonal antagonist releasing hormone JMR 132. ONKOLOGIE, 33 (Suppl2). pp. 34-35. ISSN 0378-584X
Lattrich, C. and Treeck, O. and Ortmann, O. (2010) B agonist estrogen receptor enhance the growth-inhibiting effect of trastuzumab on breast cancer cells. ONKOLOGIE, 33 (Suppl2). pp. 37-38. ISSN 0378-584X
Buchholz, S. and Weber, F. and Schally, A. and Ortmann, O. and Seitz, S. (2010) Combination of antagonists of growth hormone-releasing hormone antagonist (GHRH) with rapamycin as a potential therapy in human breast cancers. JOURNAL OF CLINICAL ONCOLOGY, 28 (15supp). ISSN 0732-183X, 1527-7755
Gevensleben, H. and Goering, U. and Buettner, R. and Heukamp, L. C. and Kunz, G. and Dimpfl, T. and Jackisch, C. and Ortmann, O. and Albert, U-S and Bender, R. and de Snoo, F. and Krijgsman, O. and Glas, A. M. and Ergoenenc, Y. H. and Vogel, C. and Dykgers, A. and Langwieder, C. and Rees, M. and Anzeneder, T. (2010) Comparison of MammaPrint (R) and TargetPrint (R) results with clinical parameters in German patients (path) with early stage breast cancer. ONKOLOGIE, 33 (Suppl2). p. 28. ISSN 0378-584X
Dausch, E. and Ortmann, O. and Dausch, D. (2010) Dry Eye Syndrome in Women's Health and Gynecology Etiology, Pathogenesis and Current Therapeutic Strategies. GEBURTSHILFE UND FRAUENHEILKUNDE, 70 (9). pp. 707-711. ISSN 0016-5751
Schimanski, S. and Wild, P. J. and Treeck, O. and Horn, F. and Sigruener, A. and Rudolph, C. and Blaszyk, H. and Klinkhammer-Schalke, M. and Ortmann, O. and Hartmann, A. and Schmitz, G. (2010) Expression of the Lipid Transporters ABCA3 and ABCA1 is Diminished in Human Breast Cancer Tissue. HORMONE AND METABOLIC RESEARCH, 42 (2). pp. 102-109. ISSN 0018-5043, 1439-4286
Goerse, R. and Fischer, K. and Pauer, A. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Ortmann, O. (2010) Influence of postoperative Tumor rests on the frequency of recurrences in Patients with Ovarian cancer in the Tumor Center Regensburg. ONKOLOGIE, 33 (Suppl2). p. 115. ISSN 0378-584X
Giese, T. and Pohl, F. and Haertl, P. and Dobler, B. and Treutwein, M. and Putnik, K. and Ortmann, O. and Koelbl, O. and Goerse, R. (2010) Introduction in Intra-operative radiation (IORT) with the INTRABEAM-system (Zeiss) as a booster for the breast-cancer patients at the University Hospital of Regensburg. STRAHLENTHERAPIE UND ONKOLOGIE, 186 (1Suppl). p. 38. ISSN 0179-7158, 1439-099X
Treeck, Oliver and Lattrich, C. and Juhasz-Boess, I. and Buchholz, S. and Pfeiler, G. and Ortmann, O. (2008) Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. BRITISH JOURNAL OF CANCER, 99 (8). pp. 1246-1250. ISSN 0007-0920
Juhasz-Boess, I. and Buechler, C. and Neumeier, M. and Ortmann, O. and Treeck, O. (2008) Adiponectin effects on gene regulation in human mammary epithelial cells and breast cancer cells. ONKOLOGIE, 31 (Suppl1). p. 37. ISSN 0378-584X
Goerse, R. and Kayser, K. and Stefanie, K. and Zeller, V. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Ortmann, O. (2008) Adjuvant endocrine therapy of patients with breast cancer registered in the cancer center Regensburg. ONKOLOGIE, 31 (Suppl1). p. 49. ISSN 0378-584X
Konwisorz, A. and Springwald, A. and Juhasz-Boess, I. and Ortmann, O. and Treeck, O. (2008) Analysis of single nucleotide polymorphisms in the promoter region of ICB-1 gene in women with breast cancer. ONKOLOGIE, 31 (Suppl1). p. 50. ISSN 0378-584X
Pfieler, G. and Wenzl, G. and Schmitz, G. and Hartmann, A. and Ortmann, O. and Treeck, O. (2008) Co-expression of genes of the insulin- and estrogen signaling system and correlation with clinical parameters in breast cancer patients. ONKOLOGIE, 31 (Suppl1). p. 33. ISSN 0378-584X
Juhasz-Boess, I. and Hottner, S. and Kerl, S. and Lattrich, C. and Ortmann, O. and Germer, U. (2008) Effect of abrasio on the sonographical staging with endometrium carcinoma. GEBURTSHILFE UND FRAUENHEILKUNDE, 68 (5): V2_01. p. 540. ISSN 0016-5751
Pfeiler, G. and Schmitz, G. and Hartmann, A. and Ortmann, O. and Treeck, O. (2008) Gene expression analysis of the insulin- and estrogen signalling system and their influence on clinical parameters of breast cancer patients. EJC SUPPLEMENTS, 6 (7). p. 101. ISSN 1359-6349
Hottner, S. and Juhasz-Boess, I and Goerse, R. and Ortmann, O. and Germer, U. (2008) Indication status for the further Ultra sound analysis at a tertiary centre for the prenatal medicine in the second trimester. GEBURTSHILFE UND FRAUENHEILKUNDE, 68 (5): P3_01. pp. 550-551. ISSN 0016-5751
Lattrich, C. and Boehringer, A. and Juhasz-Boess, I and Hottner, S. and Ortmann, O. and Germer, U. (2008) Is the invasive prenatal diagnostics still current from the age indication? GEBURTSHILFE UND FRAUENHEILKUNDE, 68 (5): V3_09. p. 545. ISSN 0016-5751
Goerse, R. and Kayser, K. and Sturm, K. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Ortmann, O. (2008) Operative therapy of the mamma carcinoma in the tumor centre of Regensburg 1998-2005. GEBURTSHILFE UND FRAUENHEILKUNDE, 68 (5): P5_03. p. 557. ISSN 0016-5751
Lattrich, C. and Treeck, O. and Juhasz-Boess, I. and Ortmann, O. (2008) Overexpression of estrogen receptor P in human breast cancer cell lines affects HER2/NEU expression in an ER alpha-dependent manner. ONKOLOGIE, 31 (Suppl1). p. 36. ISSN 0378-584X
Poelcher, M. and Mahner, S. and Ortmann, O. and Hilfrich, J. and Diedrich, K. and Breitbach, P. and Hoess, C. and Moebus, V. and Thomssen, C. and Kuhn, W. (2008) Residual disease after neoadjvant chemotherapy and debulking surgery in patients with advanced ovarian cancer (prospective, randomized phase II clinical trial to select primary chemotherapy with carboplatin and docetaxel in patients with advanced ovarian cancer stage FIGO IIIC and IV Primovar). ONKOLOGIE, 31 (Suppl1). pp. 108-109. ISSN 0378-584X
Keyver-Paik, M. -D. and Poelcher, M. and Mahner, S. and Ortmann, O. and Hilfrich, J. and Diedrich, K. and Breitbach, P. and Hoess, C. and Moebus, V. and Thomssen, C. and Kuhn, W. (2008) Response evaluation of neoadjuvant chemotherapy in advanced ovarian cancer patients (prospective, randomized phase II clinical trial to select primary chemotherapy with carboplatin and docetaxel in patients with advanced ovarian cancer stage FIGO IIIC and IV Primovar). ONKOLOGIE, 31 (Suppl1). p. 109. ISSN 0378-584X
Kayser, K. and Goerse, R. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Ortmann, O. (2008) Stadiums dependent lymphadenectomy rate in the primary therapy of the ovarial carcinoma in the draw area of the Tumor centre Regensburg. GEBURTSHILFE UND FRAUENHEILKUNDE, 68 (5): V2_02. p. 540. ISSN 0016-5751
Kayser, K. and Goerse, R. and Klappenberger, S. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Ortmann, O. (2008) Treatment of patients with relapse of ovarian cancer reported in the cancer center Regensburg. ONKOLOGIE, 31 (Suppl1). p. 103. ISSN 0378-584X
Wild, P. J. and Schimanski, S. and Treeck, O. and Ortmann, O. and Langmann, T. and Rudolph, C. and Sigruener, A. and Schalke, M. and Schmitz, G. and Hartmann, A. (2007) The ATP-binding cassette transporter ABCA3 is expressed in mammary gland epithelial cells and may constitute a novel prognostic marker for breast cancer. PATHOLOGY RESEARCH AND PRACTICE, 203 (5). p. 306. ISSN 0344-0338
Kerl, S. and Heine, N. and Eisenmann-Klein, M. and Ortmann, O. (2007) Algorithm for reconstructive procedure in oncoplastic breast surgery after mastectomy. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_16. p. 521. ISSN 0016-5751, 1438-8804
Kayser, K. and Goerse, R. and Popp, N. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Ortmann, O. (2007) Analysis of the quality of care of patients with ovarian cancer in the Regensburg Tumour Centre. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): V2_4. p. 504. ISSN 0016-5751
Horn, F. and Kriener, C. and Hartmann, A. and Ortmann, O. and Treeck, O. (2007) Analysis of the single nucleotide polymorphism rs2987983 in the promotor of the oestrogen receptor gene in breast cancer. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_07. p. 519. ISSN 0016-5751
Rudolph, C. and Sigruener, A. and Hartmann, A. and Orso, E. and Bals-Pratsch, M. and Gronwald, W. and Seifert, B. and Kalbitzer, H. R. and Verdorfer, I. and Luetjens, C. M. and Ortmann, O. and Bornstein, S. R. and Schmitz, G. (2007) ApoA-I-binding protein (AI-BP) and its homologues hYjeF_N2 and hYjeF_N3 comprise the YjeF_N domain protein family in humans with a role in spermiogenesis and oogenesis. HORMONE AND METABOLIC RESEARCH, 39 (5). pp. 322-335. ISSN 0018-5043
Pfeiler, G. and Lattrich, C. and Treeck, O. and Ortmann, O. (2007) Apoptotic effects of signal transcluction inhibitors on human tumor cells with different PTEN expression. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_28. p. 524. ISSN 0016-5751
Sanders, L. and Goerse, R. and Treeck, O. and Ortmann, O. (2007) Benign breast diseases - Etiology and clinical work-up. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (4). pp. 321-328. ISSN 0016-5751
Lattrich, C. and Seitz, S. and Buchholz, S. and Ortmann, O. (2007) Bombesin antagonists influence proliferation, EGF receptor and FOS mRNA expression in human ovarian cancer cell lines. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_33. pp. 525-526. ISSN 0016-5751
Lattrich, C. and Juhasz-Boss, I. and Ortmann, O. and Treeck, O. (2007) Detection of elevated HER2/neu levels in breast cancer cell lines overexpressing estrogen receptor beta. BREAST CANCER RESEARCH AND TREATMENT, 106 (Suppl1). S242. ISSN 0167-6806
Klappenberger, S. and Juhasz-Boess, I and Hanzlick, J. and Schwarz, S. and Ortmann, O. (2007) Inguinal leimyoma - a case report. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_122. pp. 547-548. ISSN 0016-5751
Piso, P. and Ghali, N. and Dahlke, M. H. and Popp, F. C. and Lang, S. A. and Glockzin, G. and von Breitenbuch, P. and Agha, A. and Schlitt, H. J. and Ortmann, O. (2007) Intraoperative hyperthermic intraperitoneal chemotherapy as a therapeutic option for ovarian carcinoma - Recent developments. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (12). pp. 1317-1323. ISSN 0016-5751
Buchholz, S. and Hohla, F. and Schally, A. and Engel, J. and Seitz, S. and Ortmann, O. and Varga, J. (2007) Potentiation of the tumour inhibition of experimentally-induced breast cancers through the combined application of taxotere and a GHRH antagonist. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_04. p. 518. ISSN 0016-5751
Juhasz-Boess, I. and Treeck, O. and Ortmann, O. and Malik, E. (2007) Progesterone effect on vascular surfaces- and vascular thickness index in the ectopic endometrium of patients with and without endometriosis on the chorioallantois membrane. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_121. p. 547. ISSN 0016-5751
Frimmel-Mueller, T. and Juhasz-Boess, I and Ortmann, O. and Germer, U. (2007) Reference values for the nasal bone in the first trimester. GEBURTSHILFE UND FRAUENHEILKUNDE, 67 (5): P_82. pp. 537-538. ISSN 0016-5751
Coombes, R. Charles and Kilburn, L. S. and Snowdon, C. F. and Paridaens, R. and Coleman, R. E. and Jones, S. E. and Jassem, J. and Van de Velde, C. J. H. and Delozier, T. and Alvarez, I. and Del Mastro, L. and Ortmann, O. and Diedrich, K. and Coates, A. S. and Bajetta, E. and Holmberg, S. B. and Dodwell, D. and Mickiewicz, E. and Andersen, J. and Lonning, P. E. and Cocconi, G. and Forbes, J. and Castiglione, M. and Stuart, N. and Stewart, A. and Fallowfield, L. J. and Bertelli, G. and Hall, E. and Bogle, R. G. and Carpentieri, M. and Colajori, E. and Subar, M. and Ireland, E. and Bliss, J. M. (2007) Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. LANCET, 369 (9561). pp. 559-570. ISSN 0140-6736, 1474-547X
Buchholz, S. and Schally, A. and Ortmann, O. and Florian, H. and Frank, K. and Elmar, H. and Gabor, H. and Joseph, V (2006) Inhibitory effects of combined treatment with GHRH antagonists, bombesin and docetaxel on xenografted breast cancer growth. BREAST CANCER RESEARCH AND TREATMENT, 100 (Suppl1). S72-S73. ISSN 0167-6806
Pfeiler, G. H. and Lattrich, C. and Schambeck, C. and Langmann, T. and Treeck, O. and Ortmann, O. (2006) Metabolismus und Mammakarzinom = Breast cancer and metabolism. GEBURTSHILFE UND FRAUENHEILKUNDE, 66 (9). pp. 841-851. ISSN 0016-5751, 1438-8804
Wolf, C. and Blohmer, J. U. and Ortmann, O. and Krainick, U. and Eiermann, W. (2006) Neoadjuvant exemestan alone or combined with metronomic chemotherapy (epirubicine; paclitaxel; docetaxel): efficacy plus tolerability. Final results of a multicenter phase I/II study (GENARI: German neoadjuvant arornasin initiative). BREAST CANCER RESEARCH AND TREATMENT, 100 (Suppl1). S151. ISSN 0167-6806
Weiss, J. M. and Polack, S. and Treeck, O. and Diedrich, K. and Ortmann, O. (2006) Regulation of GnRH I receptor gene expression by the GnRH agonist triptorelin, estradiol, and progesterone in the gonadotroph-derived cell line alpha T3-1. ENDOCRINE, 30 (1). pp. 139-144. ISSN 1355-008X, 1559-0100
Conference or Workshop Item
Bausewein, L. and Keil, F. and Oberschmid, B. and Grube, M. and Ortmann, O. and Seitz, S. and Hatzipanagiotou, M. E. (2023) Case Presentation: Perivascular Epithelioid Cell Tumor (PECom) of the Uterus. In: Gemeinsamer Kongress der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde (BGGF) und der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) 2023, 23.–24.06.2023, Würzburg.
Hetterich, M. and Schueler-Toprak, S. and Evert, M. and Bergler, T. and Ortmann, O. (2023) Implementation of Local Therapy with Imiquimod in an immunosuppressed Patient with recurrent Dysplasia of the Vagina and Uterine cervix. In: Gemeinsamer Kongress der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde (BGGF) und der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) 2023, 23.–24.06.2023, Würzburg.
Hatzipanagiotou, M. E. and Pigerl, M. C. and Gerken, M. and Raepple, S. and Zeltner, V and Ugocsai, P. and Ortmann, O. and Klinkhammer-Schalke, M. and Seitz, S. (2023) Influence of the Time Interval until the Start of adjuvant Chemotherapy on Overall Survival in Patients with triple-negative Breast Cancer. In: Gemeinsamer Kongress der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde (BGGF) und der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) 2023, 23.–24.06.2023, Würzburg.
Graf, M. and Gerken, M. and Klinkhammer-Schalke, M. and Schrodi, S. and Engel, J. and Pauer, A. and Ortmann, O. and Inwald, E. C. (2023) ergleich von klinischen, histopathologischen, therapeutischen Faktoren und Überleben zwischen 2510 männlichen und 307634 weiblichen Patientinnen mit bösartigen Neubildungen der Brust – Ergebnisse einer großen populationsbasierten Kohortenstudie in Deutschland = Comparison of clinical, histopathological, therapeutic Factors and Survival between 2510 male and 307634 female Patients with malignant Breast Neoplasms - Results of a large population-based Cohort Study in Germany. In: Gemeinsamer Kongress der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde (BGGF) und der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) 2023, 23.–24.06.2023, Würzburg.
Ditsch, N. and Koepke, M. B. and Haidinger, R. and Wuerstlein, R. and Welter, B. and Seitz, S. and Schumacher-Wulff, E. and Albert, U. S. and Baumgartner, T. and Aulmann, C. and Hasan, A. and Dannecker, C. and Corradini, S. and Ettl, J. and Harbeck, N. and Hinske, C. and Kiechle, M. and Kunz, M. and Koelbl, O. and Ortmann, O. and Schiele, S. and Schmid, V and Weiss, M. and Woeckel, A. and Fasching, P. and Beckmann, M. W. (2023) Ärztliches „Sich Zeit nehmen“ befürwortet – Erste Ergebnisse der WAVES-Studie im Rahmen der Diagnosemitteilung Brustkrebs = Physicians' "Taking your time" approved - First Results of the WAVES Study as a Part of Breast Cancer Diagnosis Notification. In: Gemeinsamer Kongress der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde (BGGF) und der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) 2023, 23.–24.06.2023, Würzburg.
Hatzipanagiotou, M. and Hetterich, M. and Roca Ripoll, B. and Gerthofer, V. and Ortmann, O. and Seitz, S. (2020) ABUS as an alternative to hand held ultrasound for response control in neoadjuvant breast cancer treatment. In: Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), 07.-10.10.2020, München.
Hatzipanagiotou, M. and Gerthofer, V. and Hetterich, M. and Roca, B. and Ortmann, O. and Seitz, S. (2020) ABUS as an alternative to hand held ultrasound for response control in neoadjuvant breast cancer treatment. In: 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V., 25.-27.06.2020, Congress Center München.
Ugocsai, P. and Teoman, A. and Gennari, P. and Ignatov, A. and Ortmann, O. and Seitz, S. (2020) Adapted adjuvant TC chemotherapy in primary tubal cancer after renal transplantation and chronic hepatitis C infection - a case report. In: Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), 07.-10.10.2020, München.
Teoman, A. and Meszaros, J. and Ugocsai, P. and Ortmann, O. (2020) First manifestation of a polyglandular autoimmune syndrome as acute adrenal insufficiency in the 2nd trimester of pregnancy. In: Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), 07.-10.10.2020, München.
Fernandez-Pacheco, M. and Inwald, E. C. and Gerken, M. and Ignatov, A. and Klinkhammer-Schalke, M. and Ortmann, O. (2020) Impact of Marging Shaving on Re-Excision rates in patients with primary invasive carcinoma and carcinoma in situ in Breast Conserving Surgery. Data from a population based cohort of clinical cancer registry. In: Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), 07.-10.10.2020, München.
Fernandez-Pacheco, M. and Ortmann, O. and Gerken, M. and Ignatov, A. and Klinkhammer-Schalke, M. and Inwald, E. C. (2020) Impact of Marging Shaving on Re-Excision rates in patients with primary invasive carcinoma and carcinoma in situ in Breast Conserving Surgery. Data from a population based cohort of clinical cancer registry. In: 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V., 25.-27.06.2020, Congress Center München.
Inwald, E. C. and Klinkhammer-Schalke, M. and Gerken, M. and Pauer, A. and Ortmann, O. (2020) Implementation of guideline-based Therapy in Patients with early HER2-positive Breast Cancer in clinical Routine (2006-2018) - Data from a population-based Cohort of a Clinical Cancer Registry. In: 94. Kongress der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde e. V. (BGGF), 30.07 – 01.08.2020 Absage der Veranstaltung wegen der Corona-Pandemie, Ursprünglich geplant: Kempten.
Inwald, E. C. and Klinkhammer-Schalke, M. and Gerken, M. and Pauer, A. and Ortmann, O. (2020) Implementation of guideline-compliant Therapy in Patients with early HER2-positive Breast Cancer in the routine Clinical Practice (2006-2018) - Data from a population-related Cohort of a Clinical Cancer Registry. In: 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V., 25.-27.06.2020, Congress Center München.
Schueler-Toprak, S. and Skrzypczak, M. and Weber, F. and Ortmann, O. and Treeck, O. (2020) Long non-coding RNA CCAT1 is overexpressed in endometrial cancer and regulates growth and transcriptome of endometrial adenocarcinoma cells. In: Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), 07.-10.10.2020, München.
Hetterich, M. and Gerken, M. and Ortmann, O. and Klinkhammer-Schalke, M. and Ignatov, A. (2020) Micrometastases in axillary lymph nodes and outcome of breast cancer. In: Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), 07.-10.10.2020, München.
Hetterich, M. and Gerken, M. and Ortmann, O. and Klinkhammer-Schalke, M. and Ignatov, A. (2020) Micrometastases in axillary lymph nodes and outcome of breast cancer. In: 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V., 25.-27.06.2020, Congress Center München.
Gennari, P. and Ignatov, A. and Gerken, M. and Ortmann, O. (2020) Minimally invasive vs open hysterectomy for the treatment of early cervical cancer retrospective population- based cancer registry study. In: Tagung der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), 07.-10.10.2020, München.
Gerthofer, V. and Hatzipanagiotou, M. and Eggensberger, T. and Hetterich, M. and Weber, F. and Mamilos, A. and Rotter, M. and Evert, M. and Rosenwald, A. and Ortmann, O. and Seitz, S. (2020) Pseudolymphoma as a Differential Diagnosis to Paget's Mamille Disease - Case Reports. In: 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V., 25.-27.06.2020, Congress Center München.
Huber, D. and Seitz, S. and Kast, K. and Emons, G. and Ortmann, O. (2020) Risk for breast and ovarian cancer modified by the use of oral contraceptives in BRCA1/2 mutation carriers. In: 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V., 25.-27.06.2020, Congress Center München.
Schueler-Toprak, S. and Skrzypczak, M. and Weber, F. and Ortmann, O. and Treeck, O. (2020) The long, non-coding RNA CCAT1 is overexpressed in Endometrial Cancer and regulates Growth and Transcriptome of Endometrial Cancer Cells. In: 94. Kongress der Bayerischen Gesellschaft für Geburtshilfe und Frauenheilkunde e. V. (BGGF), 30.07 – 01.08.2020 Absage der Veranstaltung wegen der Corona-Pandemie, Ursprünglich geplant: Kempten.
Lattrich, C. R. and Treeck, O. and Ortmann, O. (2009) Adiponectin differentially affects gene expression in human mammary epithelial cells and breast cancer cells. In: Primary Therapy of Early Breast Cancer 11th International Conference, 11-14 March 2009, St. Gallen, Switzerland.
Buchholz, S. and Koester, F. and Schally, A. and Krishan, A. and Papadia, A. and Ortmann, O. and Seitz, S. (2009) Combination of a Novel Growth Hormone Releasing Hormone Antagonist JMR 132 and Tamoxifen Enhances the Inhibitory Effects on Growth of ZR 75 and T47D Estrogen Dependent Human Breast Cancer Cells In Vitro and In Vivo. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.
Seitz, S. and Schally, A. V. and Papadia, A. and Rick, F. G. and Szlatonay, L. and Ortmann, O. and Engel, J. and Koester, F. and Buchholz, S. (2009) Combination of antagonists of growth hormone-releasing hormone with docetaxel as potential therapy in breast cancer in a preclinical study. In: Primary Therapy of Early Breast Cancer 11th International Conference, 11-14 March 2009, St. Gallen, Switzerland.
Fehm, T. and Mueller, V and Kasimir-Bauer, S. and Janni, W. and Loehberg, C. and Gebauer, G. and Rack, B. and Stickeler, E. and Ortmann, O. and Riethdorf, S. and Solomayer, E. and Klein, C. and Schindlbeck, C. and Kreipe, H. and Wallwiener, D. and Pantel, K. (2009) Detect-Study: Comparison of Two Techniques for the Evaluation of the HER2 Expression on Circulating Tumor Cells in Metastatic Breast Cancer. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.
Seitz, S. and Schally, A. and Papadia, A. and Glueck, S. and Calfa, C. and Ortmann, O. and Buchholz, S. (2009) Effective tumor growth inhibition of MX1 and MDA-MB-231 estrogen receptor negative human breast cancer xenografts by treatment with LHRH antagonist cetrorelix. In: 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008, San Antonio, TX.
Springwald, A. and Lattrich, C. R. and Ortmann, O. and Treeck, O. (2009) Estrogen Receptor beta Exerts Growth-Inhibitory Effects on Human Mammary Epithelial Cells. In: 32nd Annual San Antonio Breast Cancer Symposium, DEC 09-13, 2009, San Antonio, TX.
Goerse, R. and Kayser, K. and Ortmann, O. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Gerstenhauer, M. (2008) Adjuvante endokrine Therapie von Patientinnen mit primärem Mammakarzinom im Tumorzentrum Regensburg = Adjuvante endocrine therapie in patients with primary breast cancer in Tumour center Regensburg. In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Horn, F. and Elemenler, E. and Kriener, C. and Treeck, O. and Ortmann, O. (2008) Analysis of a single nucleotide polymorphism in the promoter region of estrogen receptor beta gene in women with breast cancer. In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Springwald, A. and Treeck, O. and Goerse, R. and Ortmann, O. (2008) Analysis of a single nucleotide polymorphism of icb-1 gene in women with breast cancer. In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Lattrich, C. R. and Juhasz-Boess, I and Horn, F. and Ortmann, O. and Treek, O. (2008) Gene expression changes triggered by adiponectin in human mammary epithelial and breast cancer cells. In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Hottner, S. and Lattrich, C. R. and Juhasz-Boess, I and Ortmann, O. and Germer, U. (2008) Indikation zur weiterführenden Ultraschalluntersuchung im zweiten Trimenon an ein teritäres Zentrum für Pränatalmedizin = Indication for further ultrasonography investigations during the second trimester in the Territorial centre for Prenatal medicines. In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Seitz, S. and Schally, A. V. and Treszl, A. and Papadia, A. and Ortmann, O. and Buchholz, S. (2008) Inhibition of tumor growth of MDA-MB-231 human breast cancers by targeted cytotoxic analogue of somatostatin AN-162 (AEZS-124). In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Lattrich, C. R. and Boehringer, A. and Hottner, S. and Juhasz-Boess, I and Ortmann, O. and Germer, U. (2008) Ist das Alter der Mutter heute noch eine Indikation zur invasiven pränatalen Diagnostik? = Is the mother's age nowadays still an indication for invasive prenatal diagnostic? In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Ortmann, O. and Brockhoff, G. and Treeck, O. and Buchholz, S. (2008) Novel aspects in endocrine treatment of breast cancer. In: 1. COMBATing Breast Cancer Conference, 21.–22. November 2008, Frankfurt.
Seitz, S. and Schally, A. V. and Koester, F. and Papadia, A. and Ortmann, O. and Buchholz, S. (2008) Tumor growth inhibition of MDA-MB-231 estrogen independent human breast cancer by treatment with antagonist of LHRH Cetrorelix (R). In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Kayser, K. and Goerse, R. and Ortmann, O. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Pauer, A. (2008) Versorgungsqualität der Primärtherapie von Patientinnen mit Ovarialkarzinom im Tumorzentrum Regensburg = Care Quality in primary therapy of patients with ovarian carcinoma in the Tumor Center in Regensburg. In: 57. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, 16. - 19.09.2008, Hamburg.
Other
Schueler-Toprak, S. and Weber, F. and Treeck, O. and Ortmann, O. (2018) Estrogen Receptor beta is associated with expression of cancer-associated genes and survival of ovarian cancer patients. KARGER, BASEL.
Beyer, F. and Vogt, J. and Sistermanns, J. and Kuon, J. and Kahl, C. and Alt-Epping, B. and Stevens, S. and Ahlborn, M. and Dieterich, M. and Heider, A. and Tienken, M. and Loquai, C. and Stahlhut, K. and Ruellan, A. and Kubin, T. and Dietz, A. and Oechsle, K. and Mehnert, A. and van Oorschot, B. and Thomas, M. and Ortmann, O. and Engel, C. and Lordick, F. (2018) Individual quality of life (SEIQoL) of cancer patients at diagnosis of incurability and during the course of cancer treatment - a prospective longitudinal multicenter cohort study of the Arbeitsgemeinschaft Palliativmedizin (APM). KARGER, BASEL.
Rhiem, K. and Bick, U. and Kast, K. and Niederacher, D. and Solbach, C. and Emons, G. and Witzel, I. and Brigitte, S. and Bartram, C. and Maass, N. and Lemke, J. and Kiechle, M. and Mahner, S. and Wieacker, P. and Ortmann, O. and Riess, O. and Janni, W. and Haaf, T. and Schmutzler, R. K. (2018) New structures of the German Consortium for Hereditary Breast and Ovarian Cancer. KARGER, BASEL.
Inwald, E. and Klinkhammer-Schalke, M. and Koller, M. and Zeman, F. and Ortmann, O. (2018) Screening-relevant age treshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. KARGER, BASEL.
Vogt, J. and Sistermanns, J. and Kuon, J. and Kahl, C. and Alt-Epping, B. and Stevens, S. and Ahlborn, M. and Dieterich, M. and Heider, A. and Loquai, C. and Stahlhut, K. and Ruellan, A. and Kubin, T. W. and Dietz, A. and Oechsle, K. and Mehnert, A. and van Oorschot, B. and Thomas, M. and Ortmann, O. and Lordick, F. (2018) Symptoms and palliative care needs of cancer patients at diagnosis of incurability - a pospective longitudinal multicenter cohort study of the Arbeitsgemeinschaft Palliativmedizin (APM). KARGER, BASEL.
Mueck, A. O. and Ruan, X. and Prasauskas, V. and Grob, P. and Ortmann, O. (2018) Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review. TAYLOR & FRANCIS LTD, ABINGDON.
Seitz, S. and Brockhoff, G. and Weber, F. and Klinkhammer-Schalke, M. and Zeman, F. and Ugocsai, P. and Ortmann, O. and Wege, A. (2018) The prognostic value of PD-L1/PD-1 expression and PD-L1 gene copy number on/in tumor and immune cells in triple negative breast cancer. KARGER, BASEL.
Ortmann, O. and Roesler, W. and Helbig, U. (2017) Current developments in cancer care: including the patients' perspective-3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany. SPRINGER, NEW YORK.
Inwald, F. C. and Koller, M. and Klinkharnmer-Schalke, M. and Zeman, F. and Hofstaedter, F. and Lindberg, P. and Gerstenhaver, M. and Schueler, S. and Treeck, O. and Ortmann, O. (2016) Adjuvant endocrine therapy in pre-versus postmenopausal patients with steroid hormone receptor positive breast cancer - results from a large population-based cohort of a cancer registry. KARGER, BASEL.
Vogt, J. and Kahl, C. and Sistermanns, J. and Kuon, J. and Alt-Epping, B. and Stevens, S. and Ahlborn, M. and Heider, A. and Tienken, M. and Kubin, T. and Stahlhut, K. and Oechsle, K. and Mehnert, A. and van Oorschot, B. and Thomas, M. and Ortmann, O. and Lordick, F. (2016) Assessment of disease burden and palliative care needs of patients after first diagnosis of incurable cancer - Arbeitsgemeinschaft Palliativmedizin (APM) Project of the Section B of the German Cancer Society. KARGER, BASEL.
Vogt, J. and Sistermanns, J. and Kuon, J. and Kahl, C. and Alt-Epping, B. and Stevens, S. and Ahlborn, M. and Heider, A. and Tienken, M. and Kubin, T. and Loquai, C. and Boehm, A. and Stahlhut, K. and Oechsle, K. and Mehnert, A. and van Oorschot, B. and Thomas, M. and Ortmann, O. and Lordick, F. (2016) Assessment of psychic burden and palliative care needs of patients after first diagnosis of incurable cancer - Arbeitsgemeinschaft Palliativmedizin (APM) Project of the Section B of the German Cancer Society. KARGER, BASEL.
Wege, A. K. and Schmidt, M. and Ponnathi, M. and Ortmann, O. and Lehmann, J. and Brockhoff, G. (2016) Generation of human tumor specific antibodies in humanized tumor mice (HTM). KARGER, BASEL.
Schueler-Toprak, S. and Rapsch, T. and Moegele, M. and Ortmann, O. and Lattrich, C. and Fett, B. (2016) Influence of educational videos or information sheets on the levels of knowledge and anxiety of patients consulting for cervical dysplasia. KARGER, BASEL.
Ugocsai, P. and Wege, A. K. and Weber, F. and Christ-Ponnath, J. and Ortmann, O. and Brockhoff, G. and Seitz, S. (2016) Isolation and characterization of tumor infiltrating lymphocytes in primary human breast cancer. KARGER, BASEL.
Nemec, W. and Klinkhammer-Schalke, M. and Ortmann, O. and Buchholz, S. (2015) EFFECTS OF MORCELLATION ON LONGTERM OUTCOMES IN PATIENTS WITH UTERINE LEIOMYOSARCOMA. LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA.
Lattrich, C. and Diller, M. and Schueler, S. and Buchholz, S. and Treeck, O. and Ortmann, O. (2015) Effects of estriol on growth, gene expression and ERE activation in human breast cancer cell lines. CHURCHILL LIVINGSTONE, EDINBURGH.
Wetzel, C. and Seitz, S. and Ortmann, O. (2014) Decision strategies of the multidisciplinary team for cancer treatment. KARGER, BASEL.
Schueler, S. and Lattrich, C. and Haering, J. and Treeck, O. and Ortmann, O. (2014) Effect of Estrogen Receptor beta Agonists on proliferation and gene expression of ovarian cancer cells. KARGER, BASEL.
Lattrich, C. and Diller, M. and Schueler, S. and Buchholz, S. and Treeck, O. and Ortmann, O. (2014) Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines. KARGER, BASEL.
Seiz, L. and Ignatov, T. and Modl, S. and Weissenborn, C. and Zenclussen, A. and Costa, S. Dan and Ortmann, O. and Ignatov, A. (2014) GPER-1 acts as a tumor suppressor in ovarian cancer. KARGER, BASEL.
Inwald, E. C. and Klinkhammer-Schalke, M. and Hofstaedter, F. and Zeman, F. and Koller, M. and Gerstenhauer, M. and Ortmann, O. (2014) Ki-67 is a prognostic factor in breast cancer patients - findings of a large population-based cohort of a cancer registry. KARGER, BASEL.
Schmalfeldt, B. and Mahner, S. and Hilpert, F. and Runnebaum, I and Ortmann, O. and Mustea, A. and Sehouli, J. and Harter, P. (2014) Role of radical tumor resection and hyperthermic perfusion in ovarian cancer. KARGER, BASEL.
Engel, J. and Hoenig, A. and Meyer, S. and Dietl, J. and Kwok, B. and Ortmann, O. and Hahne, J. (2014) Specific inhbitor of ERK 1/2 AEZS-131: Anticancer activity in models of human cancers with and without overactivation of ERK1/2. KARGER, BASEL.
Moegele, M. and Buchholz, S. and Lintermans, A. and Bellen, G. and Prasauskas, V. and Ortmann, O. and Grob, P. and Neven, P. and Donders, G. (2014) Vaginal estriol-lactobacilli combination (Gynoflor (R)) therapy and sexual quality of life in breast cancer patients on aromatase inhibitors with atrophic vaginitis. KARGER, BASEL.
Buchholz, S. and Lintermans, A. and Moegele, M. and Bellen, G. and Ortmann, O. and Neven, P. and Donders, G. (2013) LOCAL ESTROGEN THERAPY AND QUALITY OF LIFE IN BREAST CANCER PATIENTS ON TREATMENT WITH AROMATASE INHIBITORS. LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA.
["eprint_typename_news_item" not defined]
Gerber, B. and Ortmann, O. (2014) Prevention of Early Menopause Study (POEMS): is it possible to preserve ovarian function by gonadotropin releasing hormone analogs (GnRHa)? [["eprint_typename_news_item" not defined]]
